SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    World Health Organization. The burden of musculoskeletal conditions at the start of the new millennium: WHO technical report series 919. Geneva: World Health Organization; 2003.
  • 2
    Klussmann A, Gebhardt H, Liebers F, von Engelhardt LV, David A, Bouillon B, et al. Individual and occupational risk factors for knee osteoarthritis: study protocol of a case control study. BMC Musculoskelet Disord 2008; 9: 26.
  • 3
    D'Ambrosia RD. Epidemiology of osteoarthritis. Orthopedics 2005; 28 Suppl: S2015.
  • 4
    Woolf AD. The bone and joint decade 2000-2010. Ann Rheum Dis 2000; 59: 812.
  • 5
    Symmons D, Mathers C, Pfleger B. Global burden of osteoarthritis in the year 2000. Geneva: World Health Organization; 2003. URL: http://www.who.int/healthinfo/statistics/bod_osteoarthritis.pdf.
  • 6
    Mathers CD, Vos ET, Stevenson CE, Begg SJ. The Australian burden of disease study: measuring the loss of health from diseases, injuries and risk factors. Med J Aust 2000; 172: 5926.
  • 7
    Shane Anderson A, Loeser RF. Why is osteoarthritis an age-related disease? Best Pract Res Clin Rheumatol 2010; 24: 1526.
  • 8
    Ricci JA, Stewart WF, Chee E, Leotta C, Foley K, Hochberg MC. Pain exacerbation as a major source of lost productive time in US workers with arthritis. Arthritis Rheum 2005; 53: 67381.
  • 9
    Italian Statistics. Rome: National Institute for Statistics; 2005. URL: http://www3.istat.it/dati/catalogo/asi2005/contenuti.html.
  • 10
    Bamji AN, Dieppe PA, Haslock DI, Shipley ME. What do rheumatologists do? A pilot audit study. Br J Rheumatol 1990; 29: 2958.
  • 11
    MacLean CH, Knight K, Paulus H, Brook RH, Shekelle PG. Costs attributable to osteoarthritis. J Rheumatol 1998; 25: 22138.
  • 12
    Merx H, Dreinhofer K, Schrader P, Sturmer T, Puhl W, Gunther KP, et al. International variation in hip replacement rates. Ann Rheum Dis 2003; 62: 2226.
  • 13
    Bolon MK, Hooper D, Stevenson KB, Greenbaum M, Olsen MA, Herwaldt L, et al, for the Centers for Disease Control and Prevention Epicenters Program. Improved surveillance for surgical site infections after orthopedic implantation procedures: extending applications for automated data. Clin Infect Dis 2009; 48: 12239.
  • 14
    Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 2008; 466: 17105.
  • 15
    Hamilton H, Jamieson J. Deep infection in total hip arthroplasty. Can J Surg 2008; 51: 1117.
  • 16
    Wilson J, Charlett A, Leong G, McDougall C, Duckworth G. Rates of surgical site infection after hip replacement as a hospital performance indicator: analysis of data from the English mandatory surveillance system. Infect Control Hosp Epidemiol 2008; 29: 21926.
  • 17
    Chiew YF, Theis JC. Comparison of infection rate using different methods of assessment for surveillance of total hip replacement surgical site infections. ANZ J Surg 2007; 77: 5359.
  • 18
    Quattrin R, Brusaferro S, Turello D, Faruzzo A, Calligaris L, Causero A. Application of Hazard Analysis Critical Control Points to control surgical site infections in hip and knee arthroplasty. Orthopedics 2008; 31: 132.
  • 19
    Mahomed NN, Barrett JA, Katz JN, Phillips CB, Losina E, Lew RA, et al. Rates and outcomes of primary and revision total hip replacement in the United States Medicare population. J Bone Joint Surg Am 2003; 85-A: 2732.
  • 20
    Pedersen AB, Mehnert F, Johnsen SP, Husted S, Sorensen HT. Venous thromboembolism in patients having knee replacement and receiving thromboprophylaxis: a Danish, population-based follow-up study. J Bone Joint Surg Am 2011; 93: 12817.
  • 21
    Clagett GP, Anderson FA Jr, Heit J, Levine MN, Wheeler HB. Prevention of venous thromboembolism. Chest 1995; 108 Suppl: 31234.
  • 22
    Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients: results of meta-analysis. Ann Surg 1988; 208: 22740.
  • 23
    Cusick LA, Beverland DE. The incidence of fatal pulmonary embolism after primary hip and knee replacement in a consecutive series of 4253 patients. J Bone Joint Surg Br 2009; 91: 6458.
  • 24
    Caprini JA, Botteman MF, Stephens JM, Nadipelli V, Ewing MM, Brandt S, et al. Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States. Value Health 2003; 6: 5974.
  • 25
    Sudo A, Sano T, Horikawa K, Yamakawa T, Shi D, Uchida A. The incidence of deep vein thrombosis after hip and knee arthroplasties in Japanese patients: a prospective study. J Orthop Surg (Hong Kong) 2003; 11: 1747.
  • 26
    Yoo MC, Cho YJ, Ghanem E, Ramteke A, Kim KI. Deep vein thrombosis after total hip arthroplasty in Korean patients and D-dimer as a screening tool. Arch Orthop Trauma Surg 2009; 129: 88794.
  • 27
    Xing KH, Morrison G, Lim W, Douketis J, Odueyungbo A, Crowther M. Has the incidence of deep vein thrombosis in patients undergoing total hip/knee arthroplasty changed over time? A systematic review of randomized controlled trials. Thromb Res 2008; 123: 2434.
  • 28
    Williams O, Fitzpatrick R, Hajat S, Reeves BC, Stimpson A, Morris RW, et al, for the National Total Hip Replacement Outcome Study Steering Committee. Mortality, morbidity, and 1-year outcomes of primary elective total hip arthroplasty. J Arthroplasty 2002; 17: 16571.
  • 29
    Zhan C, Kaczmarek R, Loyo-Berrios N, Sangl J, Bright RA. Incidence and short-term outcomes of primary and revision hip replacement in the United States. J Bone Joint Surg Am 2007; 89: 52633.
  • 30
    Doro C, Dimick J, Wainess R, Upchurch G, Urquhart A. Hospital volume and inpatient mortality outcomes of total hip arthroplasty in the United States. J Arthroplasty 2006; 21 Suppl: 106.
  • 31
    Blom A, Pattison G, Whitehouse S, Taylor A, Bannister G. Early death following primary total hip arthroplasty: 1,727 procedures with mechanical thrombo-prophylaxis. Acta Orthop 2006; 77: 34750.
  • 32
    Liu SS, Della Valle AG, Besculides MC, Gaber LK, Memtsoudis SG. Trends in mortality, complications, and demographics for primary hip arthroplasty in the United States. Int Orthop 2009; 33: 64351.
  • 33
    Aynardi M, Pulido L, Parvizi J, Sharkey PF, Rothman RH. Early mortality after modern total hip arthroplasty. Clin Orthop Relat Res 2009; 467: 2138.
  • 34
    Sperati A, Picconi O, Tancioni V, Guasticchi G, Agabiti N. Outcomes of hip replacement: a hospital-based longitudinal study in Lazio region (Italy). Ann Ig 2008; 20: 14157. In Italian.
  • 35
    Kurtz S, Mowat F, Ong K, Chan N, Lau E, Halpern M. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am 2005; 87: 148797.
  • 36
    Kim S. Changes in surgical loads and economic burden of hip and knee replacements in the US: 1997–2004. Arthritis Rheum 2008; 59: 4818.
  • 37
    Allepuz A, Serra-Sutton V, Espallargues M, Salvador X, Pons JM. Hip and knee arthroplasties in Catalonia [Spain] from 1994 to 2005. Gac Sanit 2008; 22: 53440. In Spanish.
  • 38
    Stargardt T. Health service costs in Europe: cost and reimbursement of primary hip replacement in nine countries. Health Econ 2008; 17 Suppl: S920.
  • 39
    Maravic M, Landais P. Usefulness of a national hospital database to evaluate the burden of primary joint replacement for coxarthrosis and gonarthrosis in patients aged over 40 years. Osteoarthritis Cartilage 2006; 14: 6125.
  • 40
    Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008; 16: 13762.
  • 41
    Dixon T, Shaw M, Ebrahim S, Dieppe P. Trends in hip and knee joint replacement: socioeconomic inequalities and projections of need. Ann Rheum Dis 2004; 63: 82530.
  • 42
    Lubbeke A, Katz JN, Perneger TV, Hoffmeyer P. Primary and revision hip arthroplasty: 5-year outcomes and influence of age and comorbidity. J Rheumatol 2007; 34: 394400.
  • 43
    Ong KL, Mowat FS, Chan N, Lau E, Halpern MT, Kurtz SM. Economic burden of revision hip and knee arthroplasty in Medicare enrollees. Clin Orthop Relat Res 2006; 446: 228.
  • 44
    Hooper GJ, Rothwell AG, Stringer M, Frampton C. Revision following cemented and uncemented primary total hip replacement: a seven-year analysis from the New Zealand Joint Registry. J Bone Joint Surg Br 2009; 91: 4518.
  • 45
    Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am 2009; 91: 12833.
  • 46
    Ogino D, Kawaji H, Konttinen L, Lehto M, Rantanen P, Malmivaara A, et al. Total hip replacement in patients eighty years of age and older. J Bone Joint Surg Am 2008; 90: 188490.